Humoral immunity is sufficient to protect mice against Rift Valley fever encephalitis following percutaneous exposure
Abstract In humans, Rift Valley fever virus (RVFV) infection typically presents as a self-limiting febrile illness but can cause severe complications. Neurological disease manifestations are particularly concerning as they are associated with increased mortality and long-term morbidity. This study d...
Saved in:
| Main Authors: | Karina Mueller Brown, Dominique J. Barbeau, Lingqing Xu, Brian H. Bird, Anita K. McElroy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01200-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maternal vaccination with live-attenuated Rift Valley fever virus protects offspring via immune transfer
by: Austin T. Hertel, et al.
Published: (2025-07-01) -
The Risk of Nosocomial Transmission of Rift Valley Fever.
by: Nasser A Al-Hamdan, et al.
Published: (2015-12-01) -
The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis.
by: Trevor Griesman, et al.
Published: (2024-06-01) -
Seroprevalence and Geographical Distribution of Rift Valley Fever in Livestock in Sudan
by: Mohammed E. A. Mansour, et al.
Published: (2024-04-01) -
Inter-epidemic acquisition of Rift Valley fever virus in humans in Tanzania.
by: Robert David Sumaye, et al.
Published: (2015-02-01)